Striatal met-enkephalin and substance P levels are decreased in mice infected with the LP-BM5 murine leukemia virus.
Mice infected with the LP-BM5 murine leukemia virus mixture develop severe immunosuppression and an encephalopathy characterized by spatial learning deficits. Twelve weeks after infection of C57BL/6J mice with LP-BM5, significant (50-60%) reductions in Met-enkephalin and substance P levels were observed in the striatum, whereas somatostatin levels were unchanged. In addition, a 39% decrease in hypothalamic substance P concentrations was observed, with no alteration in Metenkephalin levels. The apparent selectivity of the decrease in neuropeptide concentrations indicates that a functional alteration of the primary striatal efferent neurons occurs in this infection, which may contribute to the impairment of spatial learning observed in these mice. Moreover, this decrease in striatal neuropeptide levels is similar to the neuropathological changes in basal ganglia observed in HIV-infected individuals and is consistent with previous studies suggesting that the LP-BM5-infected mouse may serve as a useful model of AIDS dementia.
Ha
J H
JH
Laboratory of Neuroscience, NIDDK, National Institutes of Health, Bethesda, Maryland 20892-0826.
Sei
Y
Y
Basile
A S
AS
D000818:Animals; D003342:Corpus Striatum / Q000378:metabolism*; D004744:Enkephalin, Methionine / Q000378:metabolism*; D009052:Leukemia Virus, Murine; D007942:Leukemia, Experimental / Q000378:metabolism*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D012192:Retroviridae Infections / Q000378:metabolism*; D013004:Somatostatin / Q000378:metabolism; D013373:Substance P / Q000378:metabolism*; D014412:Tumor Virus Infections / Q000378:metabolism
D013373:Substance P; D013004:Somatostatin; D004744:Enkephalin, Methionine